Michael J. Fox Inspired Portrayal of Parkinson's Disease

ASN-90 is under clinical development by Asceneuron and currently in Phase I for Parkinson’s Disease. According to GlobalData, Phase I drugs for Parkinson’s Disease have a 72% phase transition success ...
A new study found that Parkinson's disease patients who took dance classes experienced fewer symptoms of depression, with ...
Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, a new study ... Nov. 19, 2024 — A recently published study ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
"Parkinson's disease doesn't have to just be this disease of diminishing, but it's of new ways to move and be creating ...
Mental health symptoms of Parkinson's include mild memory and thinking problems, anxiety, dementia, depression, ...
Symptoms of Parkinson's disease typically appear gradually and worsen over time. Symptoms and the speed of progression vary from person to person. Early detection of Parkinson's can help people ...
The standard medication levodopa does not always work against tremors in Parkinson's disease, especially in stressful situations. Propranolol, however, does work during stress, providing insight into ...
Qatar University (QU), in partnership with the International Parkinson and Movement Disorder Society (MDS), has successfully concluded ...
A condition that affects thousands can be detected decades before diagnosis. Parkinson's disease, a progressive disorder of ...